
Advancing Understanding of Autosomal Recessive Limb-Girdle Muscular Dystrophy Type R18
Uncover the benefits of genetic testing for LGMDR18: early diagnosis, personalized treatment plans, family planning, and advancing research on muscular dystrophy.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Uncover the benefits of genetic testing for LGMDR18: early diagnosis, personalized treatment plans, family planning, and advancing research on muscular dystrophy.

Explore how genetic testing transforms the diagnosis and management of Autosomal Recessive Osteopetrosis 8, aiding early diagnosis, personalized care, and family planning.

Gain insights into Autosomal Recessive Spinocerebellar Ataxia 14 with genetic testing, facilitating diagnosis, family planning, and tailored treatments for improved outcomes.

Explore how genetic testing aids in early diagnosis, carrier screening, and personalized treatment of fatal infantile cardioencephalomyopathy with COX deficiency.

Explore how genetic testing is revolutionizing the diagnosis and management of Cardiofaciocutaneous Syndrome 2, enhancing patient care and family planning.

Explore Cardiofaciocutaneous Syndrome 3, its genetic cause, and the critical role of genetic testing in diagnosis, treatment, and family planning strategies.

Unlock the potential of genetic testing in diagnosing Cardiofaciocutaneous Syndrome 4. Understand mutations, personalize treatments, and guide family planning effectively.

Genetic testing aids in diagnosing the rare disorder cardiomyopathy with woolly hair, impacting heart, skin, and teeth. Key for prognosis and family planning.